Importantly, treatment with the FAK inhibitor PF573228 (10 μM) and JNK inhibitor SP600125 (30 μM) effectively abolished the PDA-induced chemoresistance in all three PC cell lines (Figure 13A–C), indicating pathway dependence. Here, PTK2 is linked to Patent ductus arteriosus.